![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/moleculin-announces-additional-positive-preliminary-interim-data-from-aml-clinical-trial-302172685.html
https://www.prnewswire.com/news-releases/moleculin-to-present-at-the-virtual-investor-pitch-conference-302170145.html
https://www.prnewswire.com/news-releases/moleculin-announces-commencement-of-nih-funded-phase-2-clinical-trial-of-stat3-inhibitor-for-the-treatment-of-glioblastoma-nu-21c06-302145199.html
https://www.prnewswire.com/news-releases/moleculin-reports-first-quarter-2024-financial-results-and-provides-corporate-update-302142697.html
https://www.prnewswire.com/news-releases/moleculin-announces-us-patent-issue-notification-for-lipid-based-delivery-technology-for-annamycin-302140466.html
https://www.prnewswire.com/news-releases/moleculin-reports-higher-aml-complete-remission-cr-rates-and-significant-durability-with-additional-interim-subject-data-302138148.html
https://www.prnewswire.com/news-releases/european-medicines-agency-ema-grants-orphan-drug-designation-for-moleculins-treatment-of-acute-myeloid-leukemia-aml-302120221.html
https://www.prnewswire.com/news-releases/moleculin-announces-presentation-of-positive-data-demonstrating-high-anti-cancer-activity-of-annamycin-and-non-cardiotoxic-properties-302112418.html
https://www.prnewswire.com/news-releases/moleculin-to-present-at-the-medinvest-biotech--pharma-investor-conference-302102695.html
https://www.prnewswire.com/news-releases/moleculin-to-participate-in-the-virtual-investor-lunch-break-the-moleculin-opportunity-302100348.html